PCYN (Procyon) Accumulated Depreciation: $-0.94 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PCYN Procyon Corp PCYN
48 GF Score
Price $0.26
View Full Analysis

What is Procyon Accumulated Depreciation?

Procyon PCYN 48 Accumulated Depreciation is $-0.94 Mil as of Jun. 2024. GuruFocus rates PCYN with a GF Score™ of 48/100.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Procyon's quarterly accumulated depreciation increased from Dec. 2023 ($-0.55 Mil) to Mar. 2024 ($-0.59 Mil) and increased from Mar. 2024 ($-0.59 Mil) to Jun. 2024 ($-0.94 Mil).

Procyon's annual accumulated depreciation increased from Jun. 2022 ($-0.27 Mil) to Jun. 2023 ($-0.33 Mil) and increased from Jun. 2023 ($-0.33 Mil) to Jun. 2024 ($-0.94 Mil).

Procyon Accumulated Depreciation Related Terms

Procyon Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Procyon's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procyon Accumulated Depreciation Chart

Procyon Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.48 -0.26 -0.27 -0.33 -0.94

Procyon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.33 -0.50 -0.55 -0.59 -0.94
PCYN
48GF Score
Procyon Corp PCYN
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procyon Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-0.94 Mil mean?
Procyon (PCYN) has a Accumulated Depreciation of $-0.94 Mil as of Jun. 2024. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Procyon and its competitors.
Is Procyon's Accumulated Depreciation too high?
Procyon's current Accumulated Depreciation is $-0.94 Mil. Overall, Procyon has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Procyon's Accumulated Depreciation compare to KAYS and YCBD?
Procyon's Accumulated Depreciation of $-0.94 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Procyon and its competitors. Procyon's current Accumulated Depreciation is $-0.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procyon stock overvalued right now?
Procyon (PCYN) has a current Accumulated Depreciation of $-0.94 Mil. The current Accumulated Depreciation is $-0.94 Mil. Procyon's overall GF Score™ is 48/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Procyon (PCYN), the current Accumulated Depreciation is $-0.94 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Procyon Business Description

Address 164 Douglas Road East, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
48GF Score

Get the complete analysis for PCYN

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price